000048426 000__ 01501cam\a22003975i\4500
000048426 001__ 48426
000048426 003__ SzGeWIPO
000048426 005__ 20230817181954.0
000048426 006__ m\\\\eo\\d\\\\\\\\
000048426 007__ cr bn |||m|||a
000048426 008__ 230714s2023    nyu|||||o|||||000|0 eng|d
000048426 035__ $$a(OCoLC)1393694297
000048426 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO
000048426 041__ $$aeng
000048426 24500 $$aIs the European patent system for (bio)pharmaceuticals in need of change?
000048426 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2023
000048426 300__ $$a1 online resource
000048426 336__ $$atext$$2rdacontent
000048426 337__ $$acomputer$$2rdamedia
000048426 338__ $$aonline resource$$bcr$$2rdacarrier
000048426 4901_ $$aInternational Review of Intellectual Property Law & Competition Law ;$$vVolume 54, Issue 2
000048426 542__ $$fhttps://1.next.westlaw.com/Copyright
000048426 588__ $$aCrossref
000048426 590__ $$aPublished online: 2023
000048426 650_0 $$aIntellectual property.$$zEuropean Union.
000048426 650_0 $$aPatents.
000048426 650_0 $$aHealth.
000048426 650_0 $$aPharmaceuticals.
000048426 650_0 $$aIntellectual property.
000048426 7001_ $$aBostyn, Sven J.R.,$$eauthor.
000048426 7731_ $$tInternational Review of Intellectual Property Law & Competition Law
000048426 7731_ $$wIIC
000048426 830_0 $$aInternational Review of Intellectual Property Law & Competition Law ;$$vVolume 54, Issue 2.
000048426 85641 $$uhttps://www.westlaw.com/Document/I3E9DF370C20411ED919CFAFE78544F56/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000048426 904__ $$aArticle
000048426 980__ $$aIIC